Prognostic impact of discrepant Ki67 and mitotic index on hormone receptor-positive, HER2-negative breast carcinoma

Inconsistencies between mitotic index (MI) and Ki67 measures have been identified in many breast tumour samples. The aim of this study was to describe the prognosis of hormone receptor-positive (HR+) HER2- tumours having discrepant MI and Ki67. We included a cohort of breast cancer patients initiall...

Full description

Bibliographic Details

Published in:	British journal of cancer 2015-09, Vol.113 (7), p.996-1002
Main Authors:	Rossi, L, Laas, E, Mallon, P, Vincent-Salomon, A, Guinebretiere, J-M, Lerebours, F, Rouzier, R, Pierga, J-Y, Reyal, F
Format:	Article
Language:	English
Subjects:	Breast Neoplasms - metabolism Breast Neoplasms - mortality Breast Neoplasms - pathology Clinical Study Female Humans Ki-67 Antigen - analysis Mitotic Index Prognosis Receptor, ErbB-2 - metabolism Receptors, Steroid - metabolism Survival Analysis
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!